Search

Search Constraints

You searched for: Author/Creator Bosse, Tjalling

Search Results

1. 2022-RA-450-ESGO Benefit of adjuvant radiotherapy depends on molecular class of early-stage endometrial cancer. (20th October 2022)

2. 2022-RA-568-ESGO Prognostic Relevance of FIGO grading is Limited to NSMP Endometrial Cancers. (20th October 2022)

3. 2022-RA-637-ESGO Five-year universal tumor screening of BRCA1/2 in epithelial ovarian carcinoma;is histotype-directed hr-deficiency testing justified?. (20th October 2022)

4. 2022-RA-648-ESGO Interpretable deep learning provides clues for prognostic refinement of the molecular endometrial cancer classification. (20th October 2022)

5. 2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I). (20th October 2022)

6. 2022-RA-825-ESGO The impact of age on prognosis in women with endometrial cancer: a pooled analysis of the PORTEC-1, -2 and -3 randomised trials. (20th October 2022)

7. 2022-RA-925-ESGO Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1–3 trials and a prospective cohort study. (20th October 2022)

8. 2022-RA-999-ESGO Clinical relevance of clinicopathological and molecular factors in women with surgically treated stage IV endometrial cancer. (20th October 2022)

9. A novel keratin 13 variant in a four‐generation family with white sponge nevus. Issue 9 (29th July 2017)

10. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy. Issue 4 (20th October 2020)